Markets:

Overview

News

Currencies

International

Treasuries

DaVita HealthCare Partner (NY:DVA)

149.82 +2.48 (+1.68%)

Streaming Delayed Price Updated: 12:35 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

DaVita (DVA) Q3 2023 Earnings Call Transcript ↗

November 07, 2023

DVA earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

DaVita: Q3 Earnings Insights ↗

November 07, 2023

Via Benzinga

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact? ↗

October 27, 2023

Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.

Via Investor's Business Daily

Buffett’s Bullish Bets: 3 Stocks Where Warren Has At Least a 25% Stake ↗

October 24, 2023

A man who likes to make big bets on businesses, these Warren Buffett stocks are his biggest ones without actually owning the business.

Via InvestorPlace

3 Stocks to Buy From the ‘Buy the Dip’ ETF ↗

October 23, 2023

It’s a lot harder than it looks to buy the dip. Using artificial intelligence to do this makes these three stocks a buy.

Via InvestorPlace

Topics Artificial Intelligence

DaVita (DVA) Q2 2023 Earnings Call Transcript ↗

August 03, 2023

DVA earnings call for the period ending June 30, 2023.

Via The Motley Fool

Earnings Outlook For DaVita ↗

August 02, 2023

Via Benzinga

6 Analysts Have This to Say About DaVita ↗

July 13, 2023

Via Benzinga

DaVita Inc. (NYSE: DVA) Climbs to New 52-Week High

July 10, 2023

Via Investor Brand Network

Stock Market Rallies, Hits Resistance; Novo Nordisk, JPMorgan, Exxon In Focus: Weekly Review ↗

October 13, 2023

The major indexes stalled at key levels amid weak breadth.

Via Investor's Business Daily

Novo Nordisk's Kidney Outcomes Trial Has Broad Industry Implications ↗

October 12, 2023

Novo Nordisk A/S (NYSE: NVO) shares got a boost this week after the drugmaker halted trials testing potential treatment for kidney failure on

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 11, 2023

Via Benzinga

Why Dialysis Stocks Plunged Today ↗

October 11, 2023

Novo Nordisk indicated one of its diabetes drugs could also be used to treat kidney disease. Here's what investors need to know.

Via The Motley Fool

Ozempic Alert: New Trial Causes DaVita (DVA) Stock to Plunge 20% ↗

October 11, 2023

Ozempic may be able to treat kidney disease. This news has sent competitor DaVita into a tailspin as DVA stock plunges.

Via InvestorPlace

Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 11, 2023

Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in...

Via Benzinga

What's Going On With Kidney Dialysis Provider Stocks Today? ↗

October 11, 2023

DaVita Inc (NYSE: DVA), Fresenius Medical Care AG (NYSE: FMS), and Baxter International Inc (NYSE: BAX) shares fel

Via Benzinga

Ozempic Is Moving a Bunch of Stocks Wednesday Morning ↗

October 11, 2023

Find out who the winners and losers are.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 11, 2023

Via Benzinga

Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

October 11, 2023

Gainers

Via Benzinga

Nasdaq, S&P 500 Set To Open Higher Ahead Of FOMC Minutes, Producer Price Inflation Data: Why This Analyst Braces For Better Market Performance Through Year-End ↗

October 11, 2023

U.S. stocks look set to start higher Wednesday, potentially extending the gains into a fourth session amid hopes of a Fed pause.

Via Benzinga

Topics Economy Stocks

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 11, 2023

Pre-market stock movers are a hot topic on Wednesday morning and we're covering all of the latest news investors need to know about!

Via InvestorPlace

Silk Road Medical, E2open And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 11, 2023

U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 10, 2023

Via Benzinga

25% of Warren Buffett's Portfolio Is Invested in These 10 Boring Stocks ↗

September 04, 2023

You probably won't see any memes made about these Buffett stocks.

Via The Motley Fool

Change of Ownership? 3 S&P 500 Giants That Should Consider Selling ↗

August 31, 2023

S&P 500 stocks consider selling their businesses for all kinds of reasons. Here are three large ones from the index that should.

Via InvestorPlace

Topics Stocks

7 Very Oversold Warren Buffett Stocks to Buy Right Now ↗

August 27, 2023

Here are seven Warren Buffett stocks to buy in a volatile market, each one showing many of the characteristics that Buffett is so fond of.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023 ↗

August 07, 2023

Via Benzinga

Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor ↗

August 22, 2023

Via Benzinga

Topics Artificial Intelligence

Elanco Animal Health, Sovos Brands, Veritiv, Graham And Other Big Stocks Moving Higher On Monday ↗

August 07, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 300 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

90% of Warren Buffett's $372 Billion Portfolio Is Invested in Only 14 Stocks ↗

July 14, 2023

Nearly $334 billion of Berkshire Hathaway's $372 billion investment portfolio is invested in just over a dozen companies.

Via The Motley Fool

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

DaVita HealthCare Partner (NY:DVA)

All News about DaVita HealthCare Partner

Starting at $3.75/week.

Subscribe Today